Target intelligence / Profile preview

Ribosomal protein SA pseudogene 38 (RPSAP38)

Target: RPSAP38
Molecular classification: Other (Processed pseudogene)

Overview

Ribosomal protein SA pseudogene 38 (RPSAP38) is classified as a processed pseudogene, meaning it arises from the retrotransposition of mRNA from the functional ribosomal protein SA gene (RPSA)[7]. Pseudogenes like RPSAP38 do not encode for active or functional proteins and are generally not transcribed or translated. The canonical ribosomal protein SA (RPSA) is a multifunctional protein involved in ribosome assembly and has a receptor function for laminin, relevant in cancer and prion diseases[3][5]. However, pseudogene variants such as RPSAP38 lack these functions and do not serve as receptors, drug targets, or biomarkers. No evidence supports any direct biological or therapeutic relevance for RPSAP38.

Other names: RPSAP38RPSA_9_557

Beyond the preview

Go deeper on Ribosomal protein SA pseudogene 38 (RPSAP38).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein SA pseudogene 38 (RPSAP38).

Explore the full profile